128 related articles for article (PubMed ID: 37344721)
1. Correction to: Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner.
Heinisch O; Zeyen T; Goldmann T; Prinz M; Huber M; Jung J; Arik E; Habib S; Slowik A; Reich A; Schulz JB; Habib P
Transl Stroke Res; 2024 Jun; 15(3):689-690. PubMed ID: 37344721
[No Abstract] [Full Text] [Related]
2. Erythropoietin Abrogates Post-Ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner.
Heinisch O; Zeyen T; Goldmann T; Prinz M; Huber M; Jung J; Arik E; Habib S; Slowik A; Reich A; Schulz JB; Habib P
Transl Stroke Res; 2022 Jun; 13(3):462-482. PubMed ID: 34628598
[TBL] [Abstract][Full Text] [Related]
3. Correction to: Erythropoietin Abrogates Post-ischemic Activation of the NLRP3, NLRC4, and AIM2 Inflammasomes in Microglia/Macrophages in a TAK1-Dependent Manner.
Heinisch O; Zeyen T; Goldmann T; Prinz M; Huber M; Jung J; Arik E; Habib S; Slowik A; Reich A; Schulz JB; Habib P
Transl Stroke Res; 2022 Oct; 13(5):860. PubMed ID: 34741750
[No Abstract] [Full Text] [Related]
4. Gonadal Hormones E2 and P Mitigate Cerebral Ischemia-Induced Upregulation of the AIM2 and NLRC4 Inflammasomes in Rats.
Habib P; Harms J; Zendedel A; Beyer C; Slowik A
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645874
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes.
Wu J; Fernandes-Alnemri T; Alnemri ES
J Clin Immunol; 2010 Sep; 30(5):693-702. PubMed ID: 20490635
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin Enhances Post-ischemic Migration and Phagocytosis and Alleviates the Activation of Inflammasomes in Human Microglial Cells.
Arik E; Heinisch O; Bienert M; Gubeljak L; Slowik A; Reich A; Schulz JB; Wilhelm T; Huber M; Habib P
Front Cell Neurosci; 2022; 16():915348. PubMed ID: 35813499
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of NLRP3, NLRC4 and AIM2 inflammasomes and their priming-associated molecules (TLR2, TLR4, Dectin-1, Dectin-2 and NFκB) in Malassezia folliculitis.
Liang N; Yang YP; Li W; Wu YY; Zhang ZW; Luo Y; Fan YM
Mycoses; 2018 Feb; 61(2):111-118. PubMed ID: 28976036
[TBL] [Abstract][Full Text] [Related]
8. Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis.
Trachalaki A; Tsitoura E; Mastrodimou S; Invernizzi R; Vasarmidi E; Bibaki E; Tzanakis N; Molyneaux PL; Maher TM; Antoniou K
Front Immunol; 2021; 12():661811. PubMed ID: 34220810
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane attenuates activation of NLRP3 and NLRC4 inflammasomes but not AIM2 inflammasome.
Lee J; Ahn H; Hong EJ; An BS; Jeung EB; Lee GS
Cell Immunol; 2016; 306-307():53-60. PubMed ID: 27423466
[TBL] [Abstract][Full Text] [Related]
10. Triggers of NLRC4 and AIM2 inflammasomes induce porcine IL-1β secretion.
Ahn H; Kim J; Kwon S; Kim PH; Kwon HM; Lee E; Lee GS
Vet Res Commun; 2018 Dec; 42(4):265-273. PubMed ID: 30097755
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of Inflammasome Activation of Macrophages and Microglia In Vitro, Part 1: Cell Preparation and Inflammasome Stimulation.
Lovotti M; Mangan MSJ; McManus RM; Shkarina K; Vasconcelos MB; Latz E
Methods Mol Biol; 2024; 2713():407-429. PubMed ID: 37639139
[TBL] [Abstract][Full Text] [Related]
12. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
Duan M; Shen M; Zhou Y; He Y; Guo Z; Ye C; Li J; Zhu L
Clin Rheumatol; 2023 Jun; 42(6):1635-1643. PubMed ID: 36418508
[TBL] [Abstract][Full Text] [Related]
13. Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis.
Guo Q; Wu Y; Hou Y; Liu Y; Liu T; Zhang H; Fan C; Guan H; Li Y; Shan Z; Teng W
Front Immunol; 2018; 9():1197. PubMed ID: 29915579
[TBL] [Abstract][Full Text] [Related]
14. HUWE1 mediates inflammasome activation and promotes host defense against bacterial infection.
Guo Y; Li L; Xu T; Guo X; Wang C; Li Y; Yang Y; Yang D; Sun B; Zhao X; Shao G; Qi X
J Clin Invest; 2020 Dec; 130(12):6301-6316. PubMed ID: 33104527
[TBL] [Abstract][Full Text] [Related]
15. Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke.
Poh L; Kang SW; Baik SH; Ng GYQ; She DT; Balaganapathy P; Dheen ST; Magnus T; Gelderblom M; Sobey CG; Koo EH; Fann DY; Arumugam TV
Brain Behav Immun; 2019 Jan; 75():34-47. PubMed ID: 30195027
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 Depletion Fails to Mitigate Inflammation but Restores Diminished Phagocytosis in BV-2 Cells After In Vitro Hypoxia.
Schölwer I; Habib P; Voelz C; Rolfes L; Beyer C; Slowik A
Mol Neurobiol; 2020 Jun; 57(6):2588-2599. PubMed ID: 32239449
[TBL] [Abstract][Full Text] [Related]
17. β-arrestin1 is critical for the full activation of NLRP3 and NLRC4 inflammasomes.
Mao K; Chen S; Wang Y; Zeng Y; Ma Y; Hu Y; Zhang H; Sun S; Wu X; Meng G; Pei G; Sun B
J Immunol; 2015 Feb; 194(4):1867-73. PubMed ID: 25582856
[TBL] [Abstract][Full Text] [Related]
18. An optimized whole blood assay measuring expression and activity of NLRP3, NLRC4 and AIM2 inflammasomes.
Grinstein L; Endter K; Hedrich CM; Reinke S; Luksch H; Schulze F; Robertson AAB; Cooper MA; Rösen-Wolff A; Winkler S
Clin Immunol; 2018 Jun; 191():100-109. PubMed ID: 29183866
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis.
Jiao Y; Nan J; Mu B; Zhang Y; Zhou N; Yang S; Zhang S; Lin W; Wang F; Xia A; Cao Z; Chen P; Pan Z; Lin G; Pan S; Bin H; Li L; Yang S
Eur J Med Chem; 2022 Mar; 232():114194. PubMed ID: 35183871
[TBL] [Abstract][Full Text] [Related]
20. SIRT3-mediated deacetylation of NLRC4 promotes inflammasome activation.
Guan C; Huang X; Yue J; Xiang H; Shaheen S; Jiang Z; Tao Y; Tu J; Liu Z; Yao Y; Yang W; Hou Z; Liu J; Yang XD; Zou Q; Su B; Liu Z; Ni J; Cheng J; Wu X
Theranostics; 2021; 11(8):3981-3995. PubMed ID: 33664876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
